» Articles » PMID: 29452808

Norepinephrine Exerts an Inotropic Effect During the Early Phase of Human Septic Shock

Overview
Journal Br J Anaesth
Publisher Elsevier
Specialty Anesthesiology
Date 2018 Feb 18
PMID 29452808
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We conducted this study to investigate whether norepinephrine increases cardiac contractility when administered during the early phase of septic shock.

Methods: We studied 38 patients with septic shock who had been resuscitated for <3 h and whose mean arterial pressure (MAP) remained <65 mm Hg. Echocardiographic variables were obtained before (T) and after either initiation or an increase in the dose of a norepinephrine infusion to increase MAP to ≥ 65 mm Hg (T). We collected left ventricular ejection fraction (LVEF), velocity-time integral of the left ventricular outflow tract (VTI), tissue Doppler imaging of mean systolic velocity of the lateral tricuspid annulus (S) and of the lateral mitral annulus (S), and tricuspid annular plane systolic excursion (TAPSE).

Results: There were significant (P<0.05) increases from T to T in MAP [mean (sd): from 56 (7) to 80 (9) mm Hg], LVEF [from 49 (13) to 56 (13)%], VTI [from 18 (5) to 20 (6) cm], S [from 10.8 (5.1) to 12.1 (5.0) cm s], TAPSE [from 1.8 (0.5) to 2.0 (0.5) cm], and S [from 13.0 (5.6) to 15.1 (6.4) cm s]. In the subgroup of 15 patients with LVEF ≤45%, significant increases in VTI [from 16 (8) to 18 (7) cm] and in LVEF [from 36 (7) to 44 (10)%] were observed.

Conclusions: Norepinephrine administration during early resuscitation in patients with septic shock increased the cardiac systolic function despite the presumed increase in left ventricular afterload secondary to the increased arterial pressure. Whether such an effect persists over time remains to be evaluated.

Clinical Trial Registration: NCT02750683.

Citing Articles

Sex- and Gender-Based Analysis on Norepinephrine Use in Septic Shock: Why Is It Still a Male World?.

Perna B, Raparelli V, Tordo Caprioli F, Blanaru O, Malacarne C, Crosetti C Microorganisms. 2024; 12(4).

PMID: 38674765 PMC: 11052153. DOI: 10.3390/microorganisms12040821.


Vasoconstriction in septic shock.

De Backer D, Hajjar L, Monnet X Intensive Care Med. 2024; 50(3):459-462.

PMID: 38358543 DOI: 10.1007/s00134-024-07332-8.


Evidence for a personalized early start of norepinephrine in septic shock.

Monnet X, Lai C, Ospina-Tascon G, De Backer D Crit Care. 2023; 27(1):322.

PMID: 37608327 PMC: 10464210. DOI: 10.1186/s13054-023-04593-5.


Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?.

Carlos Sanchez E, Pinsky M, Sinha S, Mishra R, Jahan Lopa A, Chatterjee R J Crit Care Med (Targu Mures). 2023; 9(3):138-147.

PMID: 37588181 PMC: 10425929. DOI: 10.2478/jccm-2023-0022.


The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock.

Hamzaoui O, Goury A, Teboul J J Clin Med. 2023; 12(14).

PMID: 37510705 PMC: 10380663. DOI: 10.3390/jcm12144589.